57201 studies found for:    Open Studies
Show Display Options
Rank Status Study
1 Not yet recruiting Can Adequacy of Anesthesia Depth and Quality of Recovery be Influenced by the Level of Neuromuscular Blockade?
Condition: Neuromuscular Block
Interventions: Drug: Sugammadex;   Drug: Rocuronium
2 Not yet recruiting Study of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) for On-demand Treatment of Bleeding Episodes in Patients With Hemophilia A or B With Inhibitors
Conditions: Hemophilia A With Inhibitors;   Hemophilia B With Inhibitors
Interventions: Drug: CSL689;   Drug: Eptacog alfa (activated)
3 Not yet recruiting Exercise Intensity and Appetite in Adolescents
Condition: Pediatric Obesity
Intervention: Behavioral: acute exercise
4 Recruiting Look at Food and Lose Your Fear - Evaluation of a Computerized Attention Training (CAT) for Anorexia Nervosa Patients
Condition: Anorexia Nervosa
Intervention: Behavioral: Computerized attention training (CAT)
5 Not yet recruiting Dispensing Study to Assess the Visual Performance of Optimised Prototype Contact Lenses
Conditions: Presbyopia;   Refractive Error
Interventions: Device: Etafilcon A;   Device: Lotrafilcon B;   Device: Nelfilcon A;   Device: Delefilcon A
6 Recruiting Evaluation of Genes Involved in the Duodenal Epithelial Integrity Pre and Post Treatment With Betablockers in Cirrhotics
Condition: Hepatic Cirrhosis
Intervention: Drug: Propanolol
7 Not yet recruiting 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Aducanumab (BIIB037);   Drug: Placebo
8 Recruiting Thrombin Generation Test in Patient With Liver Cirrhosis
Condition: Cirrhosis
Intervention:
9 Not yet recruiting Prepulse Inhibition (PPI) of Startle Reflex in Schizophrenia Patients Related to Type of Treatment and Illness Duration
Conditions: Inhibition (Psychology);   Schizophrenia;   Medication Adherence
Interventions: Device: PPI monitoring device protocol;   Other: Questionnaires
10 Recruiting Multi-center Clinical Study of Guli Capsules in the Treatment of Knee Osteoarthritis
Condition: Knee Osteoarthritis
Interventions: Drug: Guli capsule;   Drug: Kangguzengsheng capsule
11 Recruiting Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 FDI)
Condition: Dyslipidemia
Intervention: Drug: CKD-519 200mg / Fasting, Standard Meal, High Fat Meal
12 Recruiting Antidepressant Effects of the Glycine Receptor Antagonist AV-101 (4-chlorokynurenine) in Major Depressive Disorder
Condition: Major Depression
Interventions: Drug: AV 101 (4-Chlorokynurenine);   Other: Placebo
13 Not yet recruiting Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma
Conditions: Metastatic Malignant Neoplasm in the Lung;   Metastatic Osteosarcoma;   Recurrent Osteosarcoma
Interventions: Biological: Dinutuximab;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Biological: Sargramostim
14 Not yet recruiting TORC1/2 Inhibitor INK128 in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia
Condition: Recurrent Adult Acute Lymphoblastic Leukemia
Interventions: Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: TORC1/2 Inhibitor INK128
15 Recruiting Respiratory Syncytial Virus Human Challenge in Healthy Adult Volunteers
Condition: Host Response to RSV A2 Infection
Intervention: Biological: RSV A2 Study Agent
16 Recruiting Phase 1 and 2 Study of MEDI4736 in Combination With Olaparib or Cediranib for Advanced Solid Tumors and Recurrent Ovarian Cancer
Conditions: Ovarian Cancer;   Solid Tumors
Interventions: Drug: Olaparib;   Drug: Cediranib;   Drug: MEDI4736
17 Not yet recruiting CIP-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma
Conditions: Granulocytic Sarcoma;   Recurrent Adult Acute Myeloid Leukemia
Interventions: Drug: 6,8-Bis(benzylthio)octanoic Acid;   Drug: Cytarabine;   Procedure: Hematopoietic Cell Transplantation;   Drug: Mitoxantrone Hydrochloride
18 Not yet recruiting CER-001 Atherosclerosis Regression ACS Trial
Condition: Acute Coronary Syndromes
Intervention: Drug: CER-001
19 Recruiting Preoperative Noninvasive Hemoglobin Monitoring in Pediatric Patients
Condition: Surgery
Intervention: Other: No treatment
20 Recruiting Optimal Dose of Intravenous Oxycodone for Endotracheal Intubation
Conditions: Intubation Complication;   Blood Pressure
Interventions: Drug: 0 mg/kg of oxycodone;   Drug: 0.05 mg/kg of oxycodone;   Drug: 0.1 mg/kg of oxycodone;   Drug: 0.15 mg/kg of oxycodone;   Drug: 0.2 mg/kg of oxycodone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years